Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity – a randomized clinical trial
C.M. Denkinger, M. Janssen, U. Schäkel, J. Gall, A. Leo, P. Stelmach, S. F. Weber, J. Krisam, L. Baumann, J. Stermann, U. Merle, M. A. Weigand, C. Nusshag, L. Bullinger, J.F. Schrezenmeier, M. Bornhäuser, N. Alakel, O. Witzke, T. Wolf, M. J.G.T. Vehreschild, S. Schmiedel, M. M. Addo, F. Herth, M. Kreuter, P.-R. Tepasse, B. Hertenstein, M. Hänel, A. Morgner, M. Kiehl, O. Hopfer, M.-A. Wattad, C. C. Schimanski, C. Celik, T. Pohle, M. Ruhe, W. V. Kern, A. Schmitt, H.M. Lorenz, View ORCID ProfileM. Souto-Carneiro, View ORCID ProfileM. Gaeddert, N. Halama, S. Meuer, H.G. Kräusslich, B. Müller, P. Schnitzler, S. Parthé, R. Bartenschlager, M. Gronkowski, J. Klemmer, M. Schmitt, P. Dreger, K. Kriegsmann, R. F. Schlenk, C. Müller-Tidow
doi: https://doi.org/10.1101/2022.10.10.22280850
C.M. Denkinger
1Division of Infectious Disease and Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany
28aGerman Center for Infection Research (DZIF), partner site Heidelberg University Hospital, Heidelberg
M. Janssen
2Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
U. Schäkel
2Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
J. Gall
3NCT-Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany
A. Leo
4Institute for Clinical Transfusion Medicine and Cell Therapy Heidelberg, Heidelberg, Germany
P. Stelmach
2Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
S. F. Weber
1Division of Infectious Disease and Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany
J. Krisam
5Institute of Medical Biometry (IMBI), University of Heidelberg, Heidelberg, Germany
L. Baumann
5Institute of Medical Biometry (IMBI), University of Heidelberg, Heidelberg, Germany
J. Stermann
5Institute of Medical Biometry (IMBI), University of Heidelberg, Heidelberg, Germany
U. Merle
6Department of Internal Medicine IV, Heidelberg University Hospital, Heidelberg, Heidelberg, Germany
M. A. Weigand
7Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany
C. Nusshag
8Department of Nephrology, University of Heidelberg, Heidelberg
L. Bullinger
9Department of Hematology, Oncology and Tumor Immunology, Charité-Universita□tsmedizin Berlin, corporate member of Freie Universita□t Berlin, Humboldt-Universita□t zu Berlin, Berlin, Germany
J.F. Schrezenmeier
9Department of Hematology, Oncology and Tumor Immunology, Charité-Universita□tsmedizin Berlin, corporate member of Freie Universita□t Berlin, Humboldt-Universita□t zu Berlin, Berlin, Germany
M. Bornhäuser
10Department of Internal Medicine I, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany
N. Alakel
10Department of Internal Medicine I, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany
O. Witzke
11Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany
T. Wolf
12Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany
M. J.G.T. Vehreschild
12Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany
S. Schmiedel
13I Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
M. M. Addo
13I Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
28bpartner site Hamburg-Lübeck-Borstel-Riems, Germany
31University Medical Center Hamburg-Eppendorf, Institute for Infection Research and Vaccine Development (IIRVD); Hamburg, Germany
F. Herth
14Pneumology and Critical Care Medicine Thoraxklinik, University of Heidelberg and Translational Lung Research Center (TIRC) Heidelberg, Germany
M. Kreuter
15Center for Interstitial and Rare Lung Diseases, Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg and German Center for Lung Research (DZL), Heidelberg, Germany
P.-R. Tepasse
16Department of Medicine B, Gastroenterology and Hepatology, University Hospital Münster, Münster, Germany
B. Hertenstein
17Medical Department I, Klinikum Bremen-Mitte, Bremen, Germany
M. Hänel
18Department of Internal Medicine III, Klinikum Chemnitz gGmbH, Chemnitz, Germany
A. Morgner
18Department of Internal Medicine III, Klinikum Chemnitz gGmbH, Chemnitz, Germany
M. Kiehl
19Department I of Internal Medicine, Frankfurt (Oder) General Hospital, Frankfurt (Oder), Germany
O. Hopfer
19Department I of Internal Medicine, Frankfurt (Oder) General Hospital, Frankfurt (Oder), Germany
M.-A. Wattad
20Department of Hematology, Oncology, Palliative Care and Stem Cell Transplantation, Klinikum Hochsauerland GmbH, Meschede, Germany
C. C. Schimanski
21Department of Internal Medicine II, Klinikum Darmstadt GmbH, Darmstadt, Germany
C. Celik
21Department of Internal Medicine II, Klinikum Darmstadt GmbH, Darmstadt, Germany
T. Pohle
22Department of Internal Medicine I, Klinikum Herford, Herford, Germany
M. Ruhe
22Department of Internal Medicine I, Klinikum Herford, Herford, Germany
W. V. Kern
23Department of Medicine II, Division of Infectious Diseases and Travel Medicine, University Medical Centre Freiburg, Freiburg, Germany
A. Schmitt
2Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
H.M. Lorenz
2Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
M. Souto-Carneiro
2Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
M. Gaeddert
1Division of Infectious Disease and Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany
N. Halama
24Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany
29Department of Translational Immunotherapy (D240), German Cancer Research Center (DKFZ), Heidelberg, Germany
30Helmholtz Institute for Translational Oncology (HI-TRON), Mainz, Germany
S. Meuer
4Institute for Clinical Transfusion Medicine and Cell Therapy Heidelberg, Heidelberg, Germany
H.G. Kräusslich
25Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany
B. Müller
25Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany
P. Schnitzler
25Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany
S. Parthé
25Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany
R. Bartenschlager
26Department of Infectious Diseases, Molecular Virology, Heidelberg University Hospital, Heidelberg, Germany
M. Gronkowski
2Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
J. Klemmer
2Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
M. Schmitt
2Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
P. Dreger
2Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
K. Kriegsmann
2Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
R. F. Schlenk
2Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
3NCT-Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany
24Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany
C. Müller-Tidow
2Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
27National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted October 13, 2022.
Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity – a randomized clinical trial
C.M. Denkinger, M. Janssen, U. Schäkel, J. Gall, A. Leo, P. Stelmach, S. F. Weber, J. Krisam, L. Baumann, J. Stermann, U. Merle, M. A. Weigand, C. Nusshag, L. Bullinger, J.F. Schrezenmeier, M. Bornhäuser, N. Alakel, O. Witzke, T. Wolf, M. J.G.T. Vehreschild, S. Schmiedel, M. M. Addo, F. Herth, M. Kreuter, P.-R. Tepasse, B. Hertenstein, M. Hänel, A. Morgner, M. Kiehl, O. Hopfer, M.-A. Wattad, C. C. Schimanski, C. Celik, T. Pohle, M. Ruhe, W. V. Kern, A. Schmitt, H.M. Lorenz, M. Souto-Carneiro, M. Gaeddert, N. Halama, S. Meuer, H.G. Kräusslich, B. Müller, P. Schnitzler, S. Parthé, R. Bartenschlager, M. Gronkowski, J. Klemmer, M. Schmitt, P. Dreger, K. Kriegsmann, R. F. Schlenk, C. Müller-Tidow
medRxiv 2022.10.10.22280850; doi: https://doi.org/10.1101/2022.10.10.22280850
Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity – a randomized clinical trial
C.M. Denkinger, M. Janssen, U. Schäkel, J. Gall, A. Leo, P. Stelmach, S. F. Weber, J. Krisam, L. Baumann, J. Stermann, U. Merle, M. A. Weigand, C. Nusshag, L. Bullinger, J.F. Schrezenmeier, M. Bornhäuser, N. Alakel, O. Witzke, T. Wolf, M. J.G.T. Vehreschild, S. Schmiedel, M. M. Addo, F. Herth, M. Kreuter, P.-R. Tepasse, B. Hertenstein, M. Hänel, A. Morgner, M. Kiehl, O. Hopfer, M.-A. Wattad, C. C. Schimanski, C. Celik, T. Pohle, M. Ruhe, W. V. Kern, A. Schmitt, H.M. Lorenz, M. Souto-Carneiro, M. Gaeddert, N. Halama, S. Meuer, H.G. Kräusslich, B. Müller, P. Schnitzler, S. Parthé, R. Bartenschlager, M. Gronkowski, J. Klemmer, M. Schmitt, P. Dreger, K. Kriegsmann, R. F. Schlenk, C. Müller-Tidow
medRxiv 2022.10.10.22280850; doi: https://doi.org/10.1101/2022.10.10.22280850
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (179)
- Cardiovascular Medicine (2603)
- Dermatology (218)
- Emergency Medicine (392)
- Epidemiology (12141)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4036)
- Geriatric Medicine (380)
- Health Economics (672)
- Health Informatics (2608)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (427)
- Neurology (3807)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6476)
- Radiology and Imaging (1379)
- Respiratory Medicine (867)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (52)
- Transplantation (185)
- Urology (165)